UBS Group’s Merus Labs International Inc. MSLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-12,611
| Closed | -$16K | – | 8355 |
|
|
2017
Q2 | $16K | Buy |
12,611
+11,073
| +720% | +$11.5K | ﹤0.01% | 6482 |
|
|
2017
Q1 | $1K | Sell |
1,538
-396
| -20% | -$341 | ﹤0.01% | 7545 |
|
|
2016
Q4 | $2K | Sell |
1,934
-6,952
| -78% | -$6.39K | ﹤0.01% | 7568 |
|
|
2016
Q3 | $9K | Buy |
8,886
+6,506
| +273% | +$7.34K | ﹤0.01% | 6879 |
|
|
2016
Q2 | $3K | Sell |
2,380
-1,972
| -45% | -$2.76K | ﹤0.01% | 7381 |
|
|
2016
Q1 | $6K | Sell |
4,352
-2,681
| -38% | -$3.73K | ﹤0.01% | 6965 |
|
|
2015
Q4 | $12K | Sell |
7,033
-1,427
| -17% | -$1.94K | ﹤0.01% | 7197 |
|
|
2015
Q3 | $11K | Sell |
8,460
-186
| -2% | -$369 | ﹤0.01% | 7236 |
|
|
2015
Q2 | $20K | Buy |
8,646
+6,819
| +373% | +$16.5K | ﹤0.01% | 6888 |
|
|
2015
Q1 | $4K | Sell |
1,827
-2,728
| -60% | -$5.02K | ﹤0.01% | 8266 |
|
|
2014
Q4 | $8K | Buy |
+4,555
| New | +$6.63K | ﹤0.01% | 8653 |
|
UBS Group's MSLI Position: Q3 2017 in Review
UBS Group sold out of Merus Labs International Inc. (MSLI) in Q3 2017, closing a stake of 12,611 shares — an estimated $16K sold.
UBS Group first reported a position in MSLI in Q4 2014 and held it in 11 quarters. The position peaked at $20K in Q2 2015. 0 funds tracked by Wall St. Rank hold MSLI as of Q3 2017.
- UBS Group reported no remaining Merus Labs International Inc. position as of Q3 2017 after selling out during the quarter.
- UBS Group sold 12,611 Merus Labs International Inc. shares in Q3 2017, an estimated $16K.
- UBS Group first reported a position in Merus Labs International Inc. in Q4 2014 and held it in 11 quarters.
- UBS Group's Merus Labs International Inc. position peaked at $20K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q3 2017.
Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.